Eric Lefkofski’s Big Data Plan
In this article published May 3, 2017 by Fortune, Eric Lefkofsky, co-founder and CEO of Tempus, expresses that there is a lot of data missing from today’s medical research system. Lefkofsky explained at the Fortune Brainstorm Health conference in San Diego that while there may be no shortage of patient data, there is a lack of sources which combine both genomic information with therapeutic data. According to Lefkofsky, aside from information about a patient’s DNA and RNA makeup, clinicians also should know which treatments they are on and how they are responding.Eric Lefkofsky was personally motivated to start Tempus when his wife was diagnosed with breast cancer, and after sitting in clinics, Lefkofsky discovered that far too often, there was not enough data for oncologists to do their jobs. The idea behind Tempus is to build a platform to collect data for analysis which can be used to find patterns between treatments and results.
Eric Lefkofsky is the co-founder and CEO of Tempus, a technology company which has built an operating system to battle cancer. He is also a founding partner of Lightbank, a venture fund investing in disruptive technologies, as well as the co-founder and chairman of Groupon, a global e-commerce marketplace, and Uptake Technologies, a leading predictive analytics platform for the world’s largest industries.
In 2006, Eric Lefkofsky and his wife Liz established Lefkofsky Family Foundation to advance high-impact initiatives which enhance the lives of people in the communities it served. In addition, Lefkofski serves as a Trustee of Lurie Children’s Hospital of Chicago, The Art Institute of Chicago, The Museum of Science and Industry, and World Business Chicago. He also serves as Chairman of the Board of Trustees for Chicago’s Steppenwolf Theatre Company. Lefkofski currently holds a position as adjunct professor at the University of Chicago, and he is an author of the book “Accelerated Disruption.” He received his Bachelor’s Degree from the University of Michigan and Juris Doctorate from The University of Michigan Law School.